Canada Markets closed

Tonix Pharmaceuticals Holding Corp. (TNXP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.5400+0.3300 (+14.93%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close2.2100
Open2.3000
Bid2.8300 x 3200
Ask2.8400 x 900
Day's Range2.0800 - 2.5900
52 Week Range1.9100 - 45.4400
Volume16,461,447
Avg. Volume1,854,173
Market Cap1.26B
Beta (5Y Monthly)1.29
PE Ratio (TTM)N/A
EPS (TTM)-0.2770
Earnings DateMar 14, 2022 - Mar 18, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.70
  • Motley Fool

    Why Tonix Pharmaceuticals Continued to Plummet Today

    Tonix Pharmaceuticals (NASDAQ: TNXP) is a biotech stock that's having an absolutely awful week. On Wednesday, the company's shares fell sharply for a third straight day, closing more than 13% lower. Investors are clearly shaken by Tonix's current attempt at financial engineering.

  • GlobeNewswire

    Tonix Pharmaceuticals Extends Research Collaboration with the University of Alberta to Develop Antiviral Drugs Against SARS-CoV-2

    Tonix Exercises Option to License Antiviral Technology PlatformNEW YORK, May 18, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced it has entered into a license agreement and extended a research collaboration with the University of Alberta, a leading Canadian research university, focused on identifying and testing broad-spectrum antiviral drugs against future variants of SARS-CoV-2 and o

  • Motley Fool

    Why Tonix Pharmaceuticals Stock Is Crashing Again Today

    Shares of Tonix Pharmaceuticals Holding (NASDAQ: TNXP) were crashing 22.7% as of 10:54 a.m. ET on Tuesday. This stock split took effect today. Reverse stock splits aren't a sign that things are going well for a company.